Beam Therapeutics Inc.
BEAM
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
66.09
USD
0.36
(0.55%)
Optionable: Yes Market Cap: 4,283 M 90-day average vol: 1,314,375
Previous close: 65.73 Open: 66.59 Bid: 67.5 Ask: 67.5
52 week range
27.77 116.91
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Beam Therapeutics (NASDAQ:BEAM) one-year losses have grown faster than shareholder returns have fallen, but the stock jumps 13% this past week
Yahoo Finance 3/2/2022
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 2/28/2022
Beam Therapeutics GAAP EPS of -$0.95, revenue of $51.07M
Seeking Alpha 2/28/2022
Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results
Yahoo Finance 2/28/2022
10 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming
Yahoo Finance 2/23/2022
Top 10 Biotech Stocks to Buy According to Jeremy Green’s Redmile Group
Yahoo Finance 2/17/2022
Beam Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Yahoo Finance 2/9/2022
Beam Therapeutics (BEAM) Investor Presentation - Slideshow
Seeking Alpha 1/24/2022
Why Pfizer's Deal With Beam Therapeutics Is a Smart Move
Yahoo Finance 1/23/2022
Are Illumina and Beam Therapeutics the Healthcare Industry's Rising Stars?
Yahoo Finance 1/22/2022
Why Is Pfizer Teaming Up With Acuitas Therapeutics?
Yahoo Finance 1/22/2022
Pfizer's Partnership With Beam Therapeutics About Becoming Global Leader In mRNA/Gene Therapy
Seeking Alpha 1/19/2022
The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo
Yahoo Finance 1/17/2022
Is Beam Therapeutics a Good Stock to Buy Now?
Yahoo Finance 1/16/2022
Las Vegas Sands Stock Could See Better Luck Ahead
Yahoo Finance 1/15/2022
Pharma Stock Roundup: PFE's Research Deal With BEAM & Other Updates
Yahoo Finance 1/14/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!